dichlororibofuranosylbenzimidazole has been researched along with Rheumatoid Arthritis in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zatsepina, OV | 1 |
| Voit, R | 1 |
| Grummt, I | 1 |
| Spring, H | 1 |
| Semenov, MV | 1 |
| Trendelenburg, MF | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Rheumatoid Arthritis
| Article | Year |
|---|---|
The RNA polymerase I-specific transcription initiation factor UBF is associated with transcriptionally active and inactive ribosomal genes.
Topics: Animals; Arthritis, Rheumatoid; Autoantibodies; Cattle; Cell Line; Cell Nucleolus; Cricetinae; Dacti | 1993 |